Search

A Practical Guide to Rehabilitation in Multiple Sclerosis: 2nd Edition

Release Date: 9/30/2019Expiration Date: 9/29/2020 NEW! Rehabilitation is an integral part of comprehensive multiple sclerosis (MS) care. This highly interactive ePrimer is designed to equip the multidisciplinary rehab team with practical, evidence-based information they can use to optimize the benefits derived from rehab services for their patients with MS. The content is augmented with faculty …

2019 MS Nursing: Voices Will Be Heard

Saturday, December 07, 2019 7:00 AM – 12:00 PM (Eastern Time) TWA Hotel(212) 806-90006 Central Terminal AreaJFK International AirportJamaica, New York 11430United States Click here for more information! In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and the International Organization of Multiple …

Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient with MS and a Literature Overview

October 16, 2019 from 8:00 pm to 9:00 pm Join us for the live journal club on Wednesday, October 16, 2019 at 8 pm (ET). Series Title: Advanced Perspectives in MS: A Virtual Journal Club Series for the Advanced Practice Multiple Sclerosis Clinician Article Title: Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient …

Managing MS: A Team Approach (Aurora, CO) – Denver Airport Marriott

Saturday, November 9, 2019.  Denver Airport Marriott at Gateway Park 16455 E. 40th Circle Aurora, CO 80011 Managing MS: A Team Approach highlights the importance of rehabilitation professionals on the MS care team. The occupational therapist, physical therapist, and speech-language pathologist play a vital role in helping patients to sustain function and remain active despite …

MS Forum® VI (Washington, DC)

December 7, 2019 from 7:30 am to 1:15 pm Grand Hyatt Washington, 1000 H Street Northwest, Constitution CDE; Constitution Level, Downtown, Chinatown, Washington, District of Columbia, 20001, USA MS Forum®, now in its sixth year, will provide the latest data and advanced communication strategies for multiple sclerosis (MS). Current treatment guidelines, gender-based issues, environmental factors, …

MS Forum® VI (Philadelphia, PA)

November 9, 2019 from 7:30 am to 1:15 pm DoubleTree by Hilton Hotel Philadelphia Center City, 237, South Broad Street, Rittenhouse Square, Ormandy West; Lobby Level, Philadelphia, Philadelphia County, Pennsylvania, 19107, USA MS Forum®, now in its sixth year, will provide the latest data and advanced communication strategies for multiple sclerosis (MS). Current treatment guidelines, …

MS Forum® VI (Newport Beach, CA)

November 2, 2019 from 7:30 am to 1:15 pm Newport Beach Marriott Hotel and Spa, 900 Newport Center Drive, Cardiff; Lobby Level, Newport Center, Newport Beach, Orange County, California, 92660, USA MS Forum®, now in its sixth year, will provide the latest data and advanced communication strategies for multiple sclerosis (MS). Current treatment guidelines, gender-based …

MS Forum® VI (Miami, FL)

November 16, 2019 from 7:30 am to 1:15 pm Mandarin Oriental, Miami, 500, Brickell Key Drive, Bangkok Room, Mezzanine Level, Miami, Miami-Dade County, Florida, 33131, USA MS Forum®, now in its sixth year, will provide the latest data and advanced communication strategies for multiple sclerosis (MS). Current treatment guidelines, gender-based issues, environmental factors, and comorbidities …

IJMSC: Experience of Identity Change in People Who Reported a Diagnosis of Multiple Sclerosis: A Qualitative Inquiry

Release Date: October 1, 2019 Valid for Credit Through: October 1, 2020 Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other healthcare providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives 1) Describe the process of identity change following a diagnosis of MS. 2) …

Q&A with Experts on Immune Dysfunction in Multiple Sclerosis

Release Date: July 31, 2019Expiration Date: July 31, 2020 Description Immune dysregulation is thought to be a key factor in the pathogenesis of multiple sclerosis (MS). This insight has led to the development of immunotherapeutic agents with targeted and varied mechanisms of action. Newer immunotherapies, which offer enhanced efficacy, are also associated with immune-related toxicities …